Sleep Fragmentation and Biomarkers in Juvenile Idiopathic Arthritis

Teresa M Ward1, Weichao Yuwen2, Joachim Voss3

  • 1Department of Family and Child Nursing, School of Nursing, University of Washington, Seattle, WA, USA teward@uw.edu.

Insights

Children with juvenile idiopathic arthritis (JIA) experience fragmented sleep, impacting biomarkers like MRP8/14. Sleep fragmentation is linked to increased MRP8/14 protein concentration in JIA patients.

Area of Science:

  • Pediatric Rheumatology
  • Sleep Medicine
  • Biomarker Research

Background:

  • Juvenile idiopathic arthritis (JIA) is a chronic condition affecting children, with potential impacts on sleep quality.
  • Sleep disturbances are common but understudied in pediatric rheumatic diseases.
  • Biomarkers such as S100A12 and myeloid-related protein (MRP8/14) are implicated in inflammatory processes.

Purpose of the Study:

  • To compare sleep parameters and symptoms in children with polyarticular and extended oligoarticular JIA.
  • To investigate the association between sleep fragmentation and specific inflammatory biomarkers (S100A12, MRP8/14).

Main Methods:

  • Actigraphy was used to measure sleep duration, efficiency, and fragmentation in 40 children with JIA.
  • Participants completed validated questionnaires for fatigue, pain, and sleep habits (CSHQ).
  • Serum protein concentrations for S100A12 and MRP8/14 were measured.

Main Results:

  • A high prevalence of sleep disturbances (68%) was reported based on the CSHQ.
  • No significant group differences were found in sleep duration, efficiency, or fragmentation between JIA categories.
  • Sleep fragmentation (movement and fragmentation index) was a significant predictor of MRP8/14 protein concentration, explaining 21% of the variance.

Conclusions:

  • Fragmented sleep is prevalent in children with JIA, irrespective of disease subtype.
  • Sleep fragmentation is associated with elevated MRP8/14 levels, suggesting a link between sleep disruption and inflammation.
  • Further research is warranted to explore the interplay of sleep, medication, and biomarkers in JIA management.
Abstract